Cagrilintide also has one of the lowest GI odds ratios among the incretin and amylin compound class in a 2025 Bayesian network meta-analysis of multi-target obesity therapies the relevance for the stack is that adding cagrilintide to retatrutide may not compound GI burden as severely as adding a second GLP-1 agonist would
Why it's relevant to psoriasis: Directly inhibits NF-B activation (central to psoriatic inflammation) Reduces pro-inflammatory cytokine production Used in inflammatory bowel disease research (similar immune dysregulation) No melanin-related effects unlike full alpha-MSH Research context: KPV has shown efficacy in reducing gut inflammation in colitis models
Subgroup analyses were planned based on age group (e.g., children, adults, older adults), baseline serum Vitamin B12, and the form of Vitamin B12 used
In adult MASLD/MASH patients, the GSH/GSSG redox ratio seemed to decrease with disease severity (Hardwick et al
You shouldnt expect to see almost any cost savings for somebody whose BMI is around 30 or 31, Cawley told Stateline